• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. OXINIUM FEM HD 12/14 36 MM L/+8; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. OXINIUM FEM HD 12/14 36 MM L/+8; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED Back to Search Results
Catalog Number 71343608
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Subluxation (4525)
Date of Event 03/05/2015
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after a left thr procedure, performed on (b)(6) 2014, a revision surgery was carried out on (b)(6) 2015 due to subluxation of the hip.The r3 liner component and oxonium 36mm +8 femoral head were explanted, and a r3 constrained liner was used to treat the event.When rom was performed, no subluxation or dislocation occurred.The patient was taken to recovery in stable condition.
 
Additional Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Additional Manufacturer Narrative
H3, h6.The device was not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that, the patient had a left r3 total hip arthroplasty on (b)(6) 2014, and a revision 6-months post implantation due to ¿subluxation, left total hip.¿ the revision operative report noted, ¿once the posterior soft tissues had been opened, the hip could be subluxed posteriorly.¿ patient was revised using constrained 62-mm acetabular liner and a 28 plus 8 femoral head which matched the patient's previous construct.With the limited information provided the clinical root cause of the reported subluxation and subsequent revision cannot be confirmed and it cannot be concluded that the recurrent subluxations were associated with a mal-performance of the implant.The patient had a 2nd revision 6-years later due to prosthetic joint infection.Device batch number was not provided, thus, an evaluation of the manufacturing records could not be performed.A review of complaint history of the previous 12 months revealed similar events for the listed device.A review of the instructions for use documents for hip systems revealed that dislocation has been identified in warnings and precautions and may result from improper selection of the neck length and cup, stem positioning, muscle looseness and/or malpositioning of components.A review of the risk management file revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this product and event.At this time, we have no reason to suspect that the product failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include traumatic injury, patient anatomy, postoperative care or abnormal loading of limb.Based on this investigation, the need for corrective action is not indicated.Should the device or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OXINIUM FEM HD 12/14 36 MM L/+8
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key17939438
Report Number1020279-2023-01945
Device Sequence Number20451102
Product Code JDI
UDI-Device Identifier03596010477293
UDI-Public03596010477293
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K022958
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Device Explanted Year2015
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Consumer,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 11/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number71343608
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/20/2023
Supplement Date Received by Manufacturer11/08/2023
Initial Report FDA Received Date10/16/2023
Supplement Report FDA Received Date11/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device A
Patient Sequence Number1
Patient Age58 YR
Patient SexMale
-
-